CORONIL – 100% Cure for COVID-19 found by Baba Ramdeo’s Patanjali?
Patanjali launches Ayurvedic medicine ‘Coronil’ for COVID-19 treatment: As the whole world still fights the uphill battle against corona, each passing week has bought news that elevates from bad to worse. On June 22nd WHO recorded 150,000 worldwide cases of coronavirus in a single day. This brings the total count to over 9 million. Chief Scientist at WHO, Dr. Soumya Swaminathan, said that 2 million doses of vaccine would be ready by the end of next year whereas other frontrunners expect a cure in the final quarter of 2020. Unfortunately enough the news of extended periods of wait for the virus only adds grief caused by 474,000 deaths, increasing every day.
But July 23rd finally gave way to a ray of hope through the launch of a COVID-19 medicine by the Ayurvedic giant Patanjali.
The Launch of Coronil
The launch introduced ‘Coronil’ the ayurvedic drug that not only promises control and cure from the COVID-19 virus but also helps in its primary and secondary prevention. The launch was presided by Acharya Balakrishna (CEO of Patanjali), Baba Ramdev (Founder, Patanjali) along with the scientists and medical professionals who were part of the research and discovery of the cure. Acharya and Baba Ramdev have claimed a 100% success rate through the drug Coronil.
Acharya backed this by claiming that the drug had undergone human trials on 100 patients. The clinical trials found that 69% of the patients tested recovered from COVID-19 within 3 days while the remaining were cured within a week. Acharya also assured that all scientific rules were followed in the creation of the drug. The drug was made through the joint research by Patanjali Institute and National Institute of medical science in Jaipur. The kit offered by Patanjali currently costs Rs. 545.
The Drug Coronil is made out of important elements like Ashwagandha, Giloy, and Tulsi. The news that Ayurvedic medicine has beaten all the scientific advances may seem shocking to us but Patanjali has not been alone in the search of an alternative cure. In Maharashtra, the worst affected state, a task force was set up to look into traditional medicines for measures against the virus. China, where the virus initially originated from too had used traditional medicines in search of a cure. The Chinese government has heavily promoted these traditional medicines as treatment for COVID-19. These medicines were even sent to Iran and Italy as foreign aid.
Other Covid-19 Drugs
There are currently over 100 vaccines in progress around the world. Apart from Patanjali 3 other Indian pharma companies too have released drugs to cure the virus. Glenmark released an oral antiviral drug Fanipiranir under the name Fabifluwhich is priced at Rs.103 per pill. The drug is used to treat mild to moderate COVID-19 infections. Hetero has released Remdesivir under the brand name Conifor and Ciple launched Remdesivir under the brand name Cipremi.
The Ministry of AYUSH so far has refused to comment on Coronil. In India, ICMR (Indian Council of Medical Research) is the apex body and nodal agency for COVID-19 treatment. It too has declined to be associated with the new medicine. Top sources in Patanjali claim that Coronil has received a license as a medicine.
But despite this government notifications bar companies from advertising a cure without government approval. Although the state of the pandemic has driven us to a state of desperation, it is also important that the rescue measures we resort to are genuine. This can only be verified after a certified government-backed agency officially backs Coronils usage.
Save Upto 90% on Brokerage FeeTrade Brains' recommended top brokers to open demat and trading account in India
|No 1 STOCKBROKER IN INDIA|
Free equity & mutual fund investments | Flat ₹20 intraday and F&O trades
|GET FREE DEMAT ACCOUNT|
0 Brokerage on Equity Delivery | Rs 20 per order for Intraday and F&O trades
|GET FREE DEMAT ACCOUNT|
ZERO Brokerage on Intraday Trades | All other F&O at ₹20 per order
Aron, Bachelors in Commerce from Mangalore University, entered the world of Equity research to explore his interests in financial markets. Outside of work, you can catch him binging on a show, supporting RCB, and dreaming of visiting Kasol soon. He also believes that eating kid’s ice-cream is the best way to teach them taxes.